Arlene S. Rosenberg

665 total citations
20 papers, 397 citations indexed

About

Arlene S. Rosenberg is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Arlene S. Rosenberg has authored 20 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Dermatology, 8 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Arlene S. Rosenberg's work include Tumors and Oncological Cases (3 papers), Cancer and Skin Lesions (3 papers) and Polyomavirus and related diseases (3 papers). Arlene S. Rosenberg is often cited by papers focused on Tumors and Oncological Cases (3 papers), Cancer and Skin Lesions (3 papers) and Polyomavirus and related diseases (3 papers). Arlene S. Rosenberg collaborates with scholars based in United States, Netherlands and Canada. Arlene S. Rosenberg's co-authors include Michael L. Morgan, Stephen C. Somach, Howard Meyerson, Edmunds Reineks, Jeffery J. Auletta, Mariet C.W. Feltkamp, Sandra Livingston, Ryan T. Mott, Els van der Meijden and Siamaque Kazem and has published in prestigious journals such as PLoS ONE, Journal of the American Academy of Dermatology and Journal of Clinical Virology.

In The Last Decade

Arlene S. Rosenberg

18 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arlene S. Rosenberg United States 12 171 110 70 68 61 20 397
M. L. Geerts Belgium 10 204 1.2× 76 0.7× 48 0.7× 33 0.5× 45 0.7× 16 404
Jaroslaw Jedrych United States 11 178 1.0× 47 0.4× 81 1.2× 28 0.4× 75 1.2× 48 319
Montserrat Gilaberte Spain 16 180 1.1× 108 1.0× 148 2.1× 82 1.2× 203 3.3× 31 676
Brian L. Swick United States 14 252 1.5× 142 1.3× 215 3.1× 88 1.3× 200 3.3× 69 734
Tammie Ferringer United States 16 253 1.5× 120 1.1× 243 3.5× 58 0.9× 170 2.8× 48 654
Maria‐Magdalena Tomaszewski United States 13 268 1.6× 214 1.9× 229 3.3× 41 0.6× 140 2.3× 13 559
K Hashimoto Japan 12 103 0.6× 41 0.4× 59 0.8× 24 0.4× 33 0.5× 38 378
Senait W. Dyson United States 11 85 0.5× 135 1.2× 101 1.4× 81 1.2× 157 2.6× 21 397
Michael J. Flaig Germany 14 199 1.2× 71 0.6× 196 2.8× 17 0.3× 127 2.1× 47 586
N. Scola Germany 15 127 0.7× 46 0.4× 161 2.3× 124 1.8× 78 1.3× 27 567

Countries citing papers authored by Arlene S. Rosenberg

Since Specialization
Citations

This map shows the geographic impact of Arlene S. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlene S. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlene S. Rosenberg more than expected).

Fields of papers citing papers by Arlene S. Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arlene S. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlene S. Rosenberg. The network helps show where Arlene S. Rosenberg may publish in the future.

Co-authorship network of co-authors of Arlene S. Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Arlene S. Rosenberg. A scholar is included among the top collaborators of Arlene S. Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlene S. Rosenberg. Arlene S. Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williamson, Sarah, et al.. (2025). CD138 : A Potential Novel Diagnostic Marker for Cellular Neurothekeoma. Journal of Cutaneous Pathology. 52(5). 379–383.
2.
Lazova, Rossitza, Heather A. Anderson, Matthew J. Powell, et al.. (2019). Histopathology‐guided mass spectrometry differentiates benign nevi from malignant melanoma. Journal of Cutaneous Pathology. 47(3). 226–240. 16 indexed citations
3.
Rosenberg, Arlene S.. (2017). Reconsidering the H&E stain as the gold standard in assessing the depth of burn wounds. Journal of Cutaneous Pathology. 44(12). 1049–1050. 5 indexed citations
4.
Ferenczi, Katalin, Arlene S. Rosenberg, Timothy H. McCalmont, et al.. (2015). Herpes zoster granulomatous dermatitis: histopathologic findings in a case series. Journal of Cutaneous Pathology. 42(10). 739–745. 10 indexed citations
5.
Kazem, Siamaque, Els van der Meijden, Richard C. Wang, et al.. (2014). Polyomavirus-Associated Trichodysplasia Spinulosa Involves Hyperproliferation, pRB Phosphorylation and Upregulation of p16 and p21. PLoS ONE. 9(10). e108947–e108947. 26 indexed citations
6.
Kazem, Siamaque, Els van der Meijden, Sander Kooijman, et al.. (2011). Trichodysplasia spinulosa is characterized by active polyomavirus infection. Journal of Clinical Virology. 53(3). 225–230. 60 indexed citations
7.
Tuttle, Marie S., et al.. (2009). Pseudocarcinomatous Hyperplasia With Follicular Differentiation Overlying Basal Cell Carcinoma. American Journal of Dermatopathology. 31(6). 557–560. 6 indexed citations
8.
Reineks, Edmunds, et al.. (2009). CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti‐CD22 antibodies to peripheral blood dendritic cells. Cytometry Part B Clinical Cytometry. 76B(4). 237–248. 46 indexed citations
9.
Rosenberg, Arlene S., et al.. (2009). Merkel cell polyomavirus: an update. Journal of Cutaneous Pathology. 36(12). 1327–1329. 17 indexed citations
10.
Chang, Timothy, Stephen C. Somach, Ally-Khan Somani, et al.. (2009). The inadequacy of punch-excised melanocytic lesions: Sampling through the block for the determination of “margins”. Journal of the American Academy of Dermatology. 60(6). 990–993. 11 indexed citations
11.
Kwon, Eun Ji, et al.. (2008). The controversy and dilemma of using sentinel lymph node biopsy for diagnostically difficult melanocytic proliferations. Journal of Cutaneous Pathology. 35(11). 1075–1077. 6 indexed citations
12.
Rosenberg, Arlene S., et al.. (2005). Benign lymphangiomatous papules of the skin. Journal of the American Academy of Dermatology. 52(5). 912–913. 9 indexed citations
13.
14.
Mott, Ryan T., Arlene S. Rosenberg, Sandra Livingston, & Michael L. Morgan. (2002). Melanoma associated with pseudoepitheliomatous hyperplasia: a case series and investigation into the role of epidermal growth factor receptor. Journal of Cutaneous Pathology. 29(8). 490–497. 30 indexed citations
15.
Rosenberg, Arlene S., et al.. (2002). Rhabdomyomatous mesenchymal hamartoma: an unusual dermal entity with a report of two cases and a review of the literature. Journal of Cutaneous Pathology. 29(4). 238–243. 48 indexed citations
16.
Rosenberg, Arlene S., et al.. (2002). Malignant peripheral nerve sheath tumor with perineurial differentiation: ‘malignant perineurioma’. Journal of Cutaneous Pathology. 29(6). 362–367. 36 indexed citations
17.
Cowper, Shawn E., Arlene S. Rosenberg, & Michael L. Morgan. (2002). An Investigation of Apoptosis in Androgenetic Alopecia. American Journal of Dermatopathology. 24(3). 204–208. 17 indexed citations
18.
Rosenberg, Arlene S. & Michael L. Morgan. (2001). Cutaneous indeterminate cell histiocytosis: a new spindle cell variant resembling dendritic cell sarcoma. Journal of Cutaneous Pathology. 28(10). 531–537. 18 indexed citations
19.
Rosenberg, Arlene S. & Michael L. Morgan. (2001). Disseminated acanthamoebiasis presenting as lobular panniculitis with necrotizing vasculitis in a patient with AIDS. Journal of Cutaneous Pathology. 28(6). 307–313. 22 indexed citations
20.
Rosenberg, Arlene S., et al.. (1962). [The influence of protein deficiency on the brain. Histopathological and histochemical research].. PubMed. 3. 431–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. L. Geerts Breakdown of academic impact, for papers by Jaroslaw Jedrych Breakdown of academic impact, for papers by Montserrat Gilaberte Breakdown of academic impact, for papers by Brian L. Swick Breakdown of academic impact, for papers by Tammie Ferringer Breakdown of academic impact, for papers by Maria‐Magdalena Tomaszewski Breakdown of academic impact, for papers by K Hashimoto Breakdown of academic impact, for papers by Senait W. Dyson Breakdown of academic impact, for papers by Michael J. Flaig Breakdown of academic impact, for papers by N. Scola
Rankless by CCL
2026